| # | Drug | Count |
|---|---|---|
| 0 | ADALIMUMAB | 3 |
| 1 | AZATHIOPRINE | 3 |
| 2 | ADALIMUMAB-AATY | 2 |
| 3 | ADALIMUMAB-ADAZ | 2 |
| 4 | ADALIMUMAB-FKJP | 2 |
| 5 | ALEMTUZUMAB | 2 |
| 6 | ANAKINRA | 2 |
| 7 | BUDESONIDE | 2 |
| 8 | CEFPODOXIME PROXETIL | 2 |
| 9 | DENOSUMAB | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | CEFPODOXIME PROXETIL | 2 | 0.0020 |
| 1 | ANAKINRA | 2 | 0.0001 |
| 2 | ALEMTUZUMAB | 2 | 0.0001 |
| 3 | BRENTUXIMAB VEDOTIN | 1 | 0.0001 |
| 4 | CEFUROXIME | 1 | 0.0001 |
| 5 | BASILIXIMAB | 1 | 0.0001 |
| 6 | GENTAMICIN SULFATE | 1 | 0.0001 |
| 7 | VALGANCICLOVIR | 1 | 0.0001 |
| 8 | ADALIMUMAB-FKJP | 2 | 0.0000 |
| 9 | ADALIMUMAB-AATY | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Interleukin-5 Antagonist [EPC] | 1 | 0.0015 |
| 1 | Interleukin-1 Receptor Antagonist [EPC] | 2 | 0.0001 |
| 2 | CD52-directed Cytolytic Antibody [EPC] | 2 | 0.0001 |
| 3 | CD30-directed Immunoconjugate [EPC] | 1 | 0.0001 |
| 4 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 1 | 0.0000 |
| 5 | Purine Antimetabolite [EPC] | 3 | 0.0000 |
| 6 | Nitroimidazole Antimicrobial [EPC] | 1 | 0.0000 |
| 7 | Mood Stabilizer [EPC] | 3 | 0.0000 |
| 8 | Topoisomerase Inhibitor [EPC] | 1 | 0.0000 |
| 9 | Aminosalicylate [EPC] | 1 | 0.0000 |